The University of Kansas Medical Center
The University of Kansas Medical Center
Kansas City, Kansas, United States29 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation | Microvascular Inflammation | Recruiting | Phase 2 | 2026-10-06 | NCT07219043 | |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis | Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, hypersensitivity pneumonitis, immune system disorder, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-10-05 | NCT06329401 | |
| An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2026-10-02 | NCT06951217 | |
| A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer | cancer, neoplasm | Recruiting | Not applicable | 2026-09-24 | NCT07223463 | |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-24 | NCT06736574 | |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) | Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06081894 | |
| RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses | CNS demyelinating autoimmune disease, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, acute stress disorder, adjustment disorder, amyotrophic lateral sclerosis, anxiety disorder, autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, demyelinating disease, depressive disorder, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, metabolic disease, motor neuron disorder, multiple sclerosis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, psychiatric disorder, pulmonary fibrosis, respiratory system disorder, spinal cord disorder | Recruiting | Phase 2 | 2026-09-15 | NCT07002034 | |
| Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure | Ventricular Dysfunction, cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-09-09 | NCT06310031 | |
| Surveillance HeartCare® Outcomes Registry | Heart Transplant Rejection | Active, not recruiting | Not stated | 2026-09-03 | NCT03695601 | |
| Regenn® Therapy System Safety Study | Surgical Wound, injury | Active, not recruiting | Phase 1 | 2026-08-27 | NCT06259409 | |
| GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women | Body Composition; Estrogen Level; GLP-1; Muscle Function | Active, not recruiting | Not stated | 2026-08-07 | NCT07422987 | |
| Mechanisms of Stimulation for Pain Alleviation | Chronic Neuropathic Pain; Chronic Neuropathic Pain (Below the Shoulders); Peripheral Nerve Stimulation | Recruiting | Phase 3 | 2026-07-23 | NCT06741579 | |
| Prospective Evaluation of Upright Versus Supine CT Myelography of the Lumbar Spine | Lumbar Central Canal Stenoses; Neural Foraminal Stenoses | Enrolling by invitation | Not applicable | 2026-07-10 | NCT07456137 | |
| Interstitial Lung Disease Research Unit Biobank | Fibrosis, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary fibrosis, respiratory system disorder, sarcoidosis | Recruiting | Not stated | 2026-07-10 | NCT05392881 | |
| A Study of CDX-622 in Participants With Mild to Moderate Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 1 | 2026-07-02 | NCT07330778 | |
| Changes in Resting Metabolic Rate Following Orthopedic Surgery | Metabolism; Disorder, Postprocedural; Post Operative Nutrition; Resting Metabolic Rate | Recruiting | Not stated | 2026-06-02 | NCT06107959 | |
| The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail | Cognition; Dietary Intake Assessment; MRI; Physical Function; Pre-Frail Older Adults; Pre-frail | Active, not recruiting | Not applicable | 2026-05-14 | NCT07167277 | |
| Pain Outcomes Associated With Exogenous Hormone Therapy in Adults | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not stated | 2026-05-14 | NCT06939257 | |
| Maternal Intake of Eggs and Infant Neurodevelopment | Pregnancy Related | Recruiting | Not applicable | 2026-05-13 | NCT07583186 | |
| The Periviable GOALS Decision Support Tool | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not applicable | 2026-05-11 | NCT05264779 | |
| Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pelvic Pain, Signs and Symptoms | Recruiting | Not stated | 2026-03-23 | NCT03794466 | |
| A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | Bacterial Infections and Mycoses, Chronic Disease, Chronic Spontaneous Urticaria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hypersensitivity, Immediate, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Suppuration, alopecia, alopecia areata, atopic eczema, bacterial infectious disease, chronic urticaria, dermatitis, disorder of pilosebaceous unit, hereditary disease, hereditary skin disorder, hidradenitis, hidradenitis suppurativa, hypopigmentation of the skin, hypotrichosis, immune system disorder, psoriasis, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, skin pigmentation disorder, skin vascular disease, sweat gland disorder, urticaria, vitiligo | Active, not recruiting | Not stated | 2026-03-20 | NCT03661866 | |
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Enrolling by invitation | Phase 2 / Phase 3 | 2026-01-22 | NCT04848506 | |
| Destination Therapy Post Approval Study | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2025-08-22 | NCT03681210 | |
| Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2025-07-09 | NCT02922036 |